Search
Search Results
##search.searchResults.foundPlural##
-
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
2089PDF: 879HTML: 264 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
2017PDF: 1242HTML: 349 -
HEMATOPOIETIC STEM CELL TRANSPLANTATION IN SEVERE PEDIATRIC SICKLE CELL DISEASE: OUTCOME AND LONG-TERM COMPLICATIONS, SAUDI EXPERIENCE AT KING FAISAL SPECIALIST HOSPITAL, RIYADH, SAUDI ARABIA HCT in in Severe Pediatric Sickle Cell Disease
1437PDF: 1035HTML: 517 -
OMENTAL SPLENOSIS MIMICKING PERITONEAL CARCINOMATOSIS
233PDF: 223HTML: 40 -
An unusual cause of anemia and encephalopathy
4201PDF: 933HTML: 1550 -
THERAPEUTIC VALUE OF COMBINED THERAPY WITH DEFERASIROX AND SILYMARIN ON IRON OVERLOAD IN CHILDREN WITH BETA THALASSEMIA
2872PDF: 898HTML: 15034Therapeutic Value of Combined Therapy with Deferasirox and Silymarin on Iron Overload in Children with Beta Thalassemia: 378 -
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA: NON-RANDOMIZED STUDY WITH A MAXIMUM FOLLOW-UP OF MORE THAN 22 YEARS
1644PDF: 982HTML: 2015Figure: 220Tables: 231ALL revision 1: 328response to reviewer: 229 -
How I treat acute and persistent sickle cell pain
2137PDF: 1195HTML: 801 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
2071PDF: 854HTML: 621 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
784PDF: 505HTML: 6290 -
CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH
1811PDF: 807HTML: 2361 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2667PDF: 1801HTML: 719 -
Allogeneic transplantation in patients with advanced systemic mastocytosis: case report of a single center experience Allogeneic Transplantation in Systemic Mastocytosis
2152PDF: 169HTML: 46 -
Calreticulin mutation survey by high resolution melting method associated with unique presentations in essential thrombocythemic patients CALR mutation survey by HRM in ET patients
1403PDF: 812HTML: 560 -
-
PERIOPERATIVE MANAGEMENT OF SICKLE CELL DISEASE: A NARRATIVE REVIEW
10717PDF: 3376HTML: 1651 -
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All Trans Retinoic Acid: A Monocentric Experience. Coagulopathy in APL treated with ATRA and Arsenic Trioxide.
1261PDF: 1182HTML: 513 -
Microangiopathic Anemia of Acute Brucellosis – is it a True TTP?
1281PDF: 849HTML: 1795 -
FAMILIAL MEDITERRANEAN FEVER AND HYPERCOAGULABILITY
1322PDF: 772HTML: 1271 -
Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia
3497PDF: 1045HTML: 3182flowcytometric result of peripheral blood sample: 260 -
MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
2910PDF: 1240HTML: 3324 -
The diagnostic pitfalls of mucormycosis
1058PDF: 776HTML: 305 -
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1619PDF: 972HTML: 1027figures: 235table 1: 236table2: 237table3: 246 -
ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
1769PDF: 880HTML: 971cover letter: 359







